Mark Hampson

Amplification of the Driving Oncogene, <i>KRAS</i> or <i>BRAF</i> , Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells

Annette S. Little, Kathryn Balmanno, Matthew J. Sale et al. · Science Signaling · 2011 · 208 citations

Medicine, Cancer Biology, Oncology +17

Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance

Victoria Chell, Kathryn Balmanno, Annette S. Little et al. · Oncogene · 2012 · 141 citations

Medicine, Cancer Biology, Oncology +14

Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation

Claire L. Cope, Rebecca Gilley, Kathryn Balmanno et al. · Journal of Cell Science · 2013 · 78 citations · Full text

Life Sciences, Oncology, Pharmacology +17

A Correction to the Research Article Titled: “Amplification of the Driving Oncogene, <i>KRAS</i> or <i>BRAF</i> , Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells” by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook

Annette S. Little, Kathryn Balmanno, Matthew J. Sale et al. · Science Signaling · 2011 · 44 citations

Medicine, Genetics, Oncology +17

Sialin, an anion transporter defective in sialic acid storage diseases, shows highly variable expression in adult mouse brain, and is developmentally regulated

Natalia Yarovaya, Rachel Schot, Lisa R. Fodero et al. · Neurobiology of Disease · 2005 · 36 citations · Full text

Life Sciences, Neurobiology, Neuroscience +9